Elanco Animal Health Incorporated (ELAN) Stock Analysis & Investment Frameworks
Elanco Animal Health Incorporated (ELAN) stock analysis on Invetso. Review Elanco Animal Health Incorporated’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Elanco Animal Health Incorporated Company Overview
- Exchange: New York Stock Exchange
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Country: US
Elanco Animal Health Incorporated Key Financial Metrics
- Market Cap: $12.99B
- Revenue: $4.71B
- ROE: -2.24%
- ROIC: 4.44%
- Dividend Yield: N/A
About Elanco Animal Health Incorporated
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
Elanco Animal Health Incorporated Investment Frameworks
Invetso analyzes Elanco Animal Health Incorporated (ELAN) across the following frameworks:
- Elanco Animal Health Incorporated 10Y Growth Potential
- Elanco Animal Health Incorporated Scenario Analysis
- Elanco Animal Health Incorporated Risks & Opportunities
- Elanco Animal Health Incorporated Economic Moat
- Elanco Animal Health Incorporated Business Model
- Elanco Animal Health Incorporated Management
- Elanco Animal Health Incorporated SWOT Analysis
- Elanco Animal Health Incorporated Porter's 5 Forces
- Elanco Animal Health Incorporated PESTLE Analysis
- Elanco Animal Health Incorporated ESG Analysis